Yüklüyor......
Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities
Recombinant human erythropoietin (rhEPO) is receiving increasing attention as a potential therapy for prevention of injury and restoration of function in nonhematopoietic tissues. However, the minimum effective dose required to mimic and augment these normal paracrine functions of erythropoietin (EP...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
National Academy of Sciences
2006
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1458681/ https://ncbi.nlm.nih.gov/pubmed/16585502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0601377103 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|